In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.

From fine-tuning open source models to building agentic frameworks on top of them, the open source world is ripe with projects that support AI development.

Hewlett Packard Enterprise Inc. is tuning up its artificial intelligence portfolio with today’s announcement of a new set of hybrid cloud offerings for machine learning development, data analytics, AI ...

Artificial intelligence/Machine Learning-driven modeling reduces time-to-market for faster Design Technology Co-Optimization development and accelerates model parameter extraction for advanced nodes, ...

The new toolkit integrates with Keysight’s device modeling software to automate parameter extraction and shorten compact-model and PDK development cycles.

Software supply chain company JFrog Ltd. announced today a new integration with Amazon SageMaker to enable developers and data scientists to collaborate efficiently on building, training and deploying ...

Keysight Technologies has released the new Machine Learning Toolkit in the latest Keysight Device Modelling Software Suite. This new solution reduces model development and extraction time from weeks ...

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions.